MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells
Piergiuseppe De Rosa(University of Bologna), Giovanni Perini(University of Bologna)
Cited by 8
Related Papers
24 (PB012): Runx1t1 is an epigenetic regulator essential for MYCN-driven neuroblastoma tumorigenesis
|European Journal of Cancer|2024|0